Biocon-PiSA Gear To Mount US Insulin Challenge
This article was originally published in Scrip
Executive Summary
Biocon and Laboratorios PiSA SA de CV of Mexico have cemented their ties further and will now co-develop and commercialize generic recombinant human insulin for the US market.